Incidence of Hepatocellular Carcinoma in Type 2 Diabetes with Cirrhosis Who Were Treated with Metformin

被引：0
|
作者：
Tangjarusritaratorn, Thanida
Kunavisarut, Tada
Tangjittipokin, Watip
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-1605-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1605-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Discontinuation of metformin in type 2 diabetes patients treated with insulin
    Wulffelé, MG
    Kooy, A
    Lehert, P
    Bets, D
    Oom, JA
    van der Burg, BB
    Donker, AJM
    Stehouwer, CDA
    NETHERLANDS JOURNAL OF MEDICINE, 2002, 60 (06): : 249 - 252
  • [22] A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes
    Ajmera, Veeral
    Cepin, Sandra
    Tesfai, Kaleb
    Hofflich, Heather
    Cadman, Karen
    Lopez, Scarlett
    Madamba, Egbert
    Bettencourt, Ricki
    Richards, Lisa
    Behling, Cynthia
    Sirlin, Claude B.
    Loomba, Rohit
    JOURNAL OF HEPATOLOGY, 2023, 78 (03) : 471 - 478
  • [23] Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy
    Riedel, Aylin A.
    Heien, Herbert
    Wogen, Jenifer
    Plauschinat, Craig A.
    PHARMACOTHERAPY, 2007, 27 (08): : 1102 - 1110
  • [24] Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
    Dziegielewska-Gesiak, Sylwia
    Fatyga, Edyta
    Pilot, Magdalena
    Wierzgon, Aleksander
    Muc-Wierzgon, Malgorzata
    DIABETES METABOLIC SYNDROME AND OBESITY, 2022, 15 : 3589 - 3599
  • [25] Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis
    Ganne-Carrie, Nathalie
    Chaffaut, Cendrine
    Bourcier, Valerie
    Archambeaud, Isabelle
    Perarnau, Jean-Marc
    Oberti, Frederic
    Roulot, Dominique
    Moreno, Christophe
    Louvet, Alexandre
    Dao, Thong
    Moirand, Romain
    Goria, Odile
    Nguyen-Khac, Eric
    Carbonell, Nicolas
    Antonini, Teresa
    Pol, Stanislas
    de Ledinghen, Victor
    Ozenne, Violaine
    Henrion, Jean
    Peron, Jean-Marie
    Tran, Albert
    Perlemuter, Gabriel
    Amiot, Xavier
    Zarski, Jean-Pierre
    Beaugrand, Michel
    Chevret, Sylvie
    JOURNAL OF HEPATOLOGY, 2018, 69 (06) : 1274 - 1283
  • [26] Influence of diabetes mellitus and effectiveness of metformin on hepatocellular carcinoma
    Ono, Masafumi
    Fujita, Koji
    Kobayashi, Kiyoyuki
    Masaki, Tsutomu
    HEPATOLOGY RESEARCH, 2023, 53 (07) : 579 - 594
  • [27] Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis
    Yen, Fu-Shun
    Huang, Yi-Hsiang
    Hou, Ming-Chih
    Hwu, Chii-Min
    Lo, Yu-Ru
    Shin, Shyi-Jang
    Hsu, Chih-Cheng
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (01) : 311 - 322
  • [28] The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes
    Smiechowski, Brielan B.
    Azoulay, Laurent
    Yin, Hui
    Pollak, Michael N.
    Suissa, Samy
    DIABETES CARE, 2013, 36 (01) : 124 - 129
  • [29] Metformin and the Incidence of Viral Associated Cancers in Patients with Type 2 Diabetes
    Hicks, Blanaid
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 473 - 474
  • [30] Metformin and the incidence of viral associated cancers in patients with type 2 diabetes
    Hicks, Blanaid M.
    Yin, Hui
    Sinyavskaya, Liliya
    Suissa, Samy
    Azoulay, Laurent
    Brassard, Paul
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (01) : 121 - 128
12345